ArticlePharmacology research & perspectives2026
Clinical-Pharmacological Drug Information Center of Hannover Medical School: Update From a Tertiary Care University Hospital (2022-2024).
Article in Pharmacology research & perspectives, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical-pharmacological medication reviews for insurants of a German statutory health insurance fund (Kaufmännische Krankenkasse (KKH)): a 5-year retrospective analysis (2019-2023).Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Court rulings on medication errors in Germany: focus on heparin, acetylsalicylic acid, and oxytocin.Naunyn-Schmiedeberg's archives of pharmacology · 2026Article
- Medication-safety burden of omeprazole in psychiatric inpatients: A retrospective cross-sectional study.The Journal of international medical research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug information centers (DICs) are institutions dedicated to providing independent and up-to-date information on medications and their usage to healthcare professionals. Here, we provide an update from the clinical-pharmacological DIC of Hannover Medical School, covering the period from April 2022 to December 2024. In total, 438 queries were evaluated. Potential differences between patient-specific and general queries were analyzed with Pearson's chi-squared test or Fisher's exact test. The Holm-Bonferroni method was applied to counteract the problem of multiple comparisons. A curated selection of ten clinically interesting and educational queries is presented and discussed. 85.2% of the queries were patient-specific, and 95.7% were submitted by physicians, predominantly internists, psychiatrists, and surgeons. Indications/contraindications, adverse drug reactions, and pharmacodynamic interactions (PDIs) represented the three most frequent query categories. Compared to our previous research, we observed increases in queries about pharmacotherapy in advanced age and drug use during pregnancy or breastfeeding. As compared to general queries, patient-specific queries were significantly more often related to indications/contraindications (26.2% vs. 49.6%; p < 0.001) and PDIs (24.6% vs. 44.5%, p = 0.003) after adjusting for multiple comparisons. The query characteristics remained relatively stable between our previous investigation and the current analysis (2022-2024), in particular with respect to type of queries, profession of inquiring healthcare professionals, medical specialties of inquirers, and query categories. Changes mainly pertained to higher proportions of queries about pharmacotherapy in advanced age and drug use during pregnancy or breastfeeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.